MHRA Approves New Treatment for Malignant Ascites Dr Sheena Meredith

https://www.medscape.com/viewarticle/mhra-approves-new-treatment-malignant-ascites-2026a10011q2?src= The Medicines and Healthcare products Regulatory Agency (MHRA) has approved catumaxomab (Korjuny, Lindis Biotech) to treat malignant ascites in adults when standard treatment of their cancer is no longer feasible.